iNtRON Biotechnology Inc (048530) — Long-term Investment Intensity
iNtRON Biotechnology Inc (048530) has a Long-term Investment Intensity of 1.2% as of December 2019. Long-term investments of ₩1.07 Billion represent 1.2% of total assets of ₩89.03 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 048530 net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
iNtRON Biotechnology Inc Long-term Investment Intensity (2012–2019)
This chart shows how iNtRON Biotechnology Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2012 to 2019. As of December 2019, the intensity stands at 1.2%, reflecting long-term investments of ₩1.07 Billion against total assets of ₩89.03 Billion KRW. Also explore balance sheet size of iNtRON Biotechnology Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for iNtRON Biotechnology Inc (2012–2019)
The table below presents the year-by-year Long-term Investment Intensity for iNtRON Biotechnology Inc from 2012 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 048530 market cap.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.2% | ₩1.07 Billion | ₩89.03 Billion | ▼ -0.7 pp |
| 2018 | 1.9% | ₩1.05 Billion | ₩54.80 Billion | ▼ -3.4 pp |
| 2017 | 5.3% | ₩2.43 Billion | ₩45.63 Billion | ▲ +0.5 pp |
| 2016 | 4.8% | ₩2.89 Billion | ₩59.61 Billion | ▼ -2.1 pp |
| 2015 | 6.9% | ₩2.80 Billion | ₩40.37 Billion | ▲ +6.1 pp |
| 2012 | 0.8% | ₩161.14 Million | ₩19.64 Billion | — |